Protalix Biotherapeutics, Inc. PLX
AMEX · United States · Health Technology
$2.71+0.03 (+1.12%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | 0.05 | -0.01 | +600.0% | $19.90M | +53.6% | -2.9%$2.43→$2.36 |
| Q1 2026 | 2026-05-13 | 0.22 | -0.01 | +2,300.0% | — | — | +4.7%$1.91→$2.00 |
| Q4 2025 | 2026-03-18 | -0.07 | 0.01 | -800.0% | — | — | -20.1%$2.79→$2.23 |
| Q3 2025 | 2025-11-13 | 0.03 | 0.06 | -50.0% | — | — | -13.1%$2.14→$1.86 |
| Q2 2025 | 2025-08-14 | 0.00 | 0.03 | -100.0% | — | — | — |
| Q1 2025 | 2025-05-09 | -0.05 | 0.08 | -162.5% | — | — | — |
| Q4 2024 | 2025-03-17 | 0.09 | 0.07 | +28.6% | — | — | — |
| Q3 2024 | 2024-11-14 | 0.03 | 0.06 | -50.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.